abstract |
This disclosure relates to compounds of formula (II), wherein the variables are defined in the disclosure, and a use of phenyl ureas of formula (I), wherein the variables are defined in the disclosure, in the treatment of disease states mediated by the chemokine, Interleukin-8 (IL-8). |